NDC 50090-3131-01 - Liothyronine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-3131
- Requested NDC
- 50090-3131-01
- Package NDCs from labels
- 50090-3131-1, 50090-3131-0, 50090-3131-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-01-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Liothyronine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2024-01-26 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3131-0 | Liothyronine Sodium | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-3131-1 | Liothyronine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3131 | LIOTHYRONINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240131_db65bcd8-e9c9-4095-9975-03be1f443823.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3131-0 | EA - Each | 50090-3131 | 3d498542-a062-421a-b60c-9774e6a8f039 | 1 | 2019-05-02 |
| 50090-3131-1 | EA - Each | 50090-3131 | c4aa75a3-337b-4005-8165-b1a670c350b1 | 1 | 2019-05-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | 31a11006-8122-49fc-8769-a28a359ac526 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | 7efdd16d-37e6-4dc8-a6c5-5b42c4813379 | 2023-11-21 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903697 GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Bryant Ranch Prepack | 20cbf84d-80f2-4b94-ad47-6aaa362fb4d0 | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903703 GCA9VV7D2N |
| liothyronine sodium | LIOTHYRONINE SODIUM | Sun Pharmaceutical Industries, Inc. | 892e63ef-3a60-45fa-b12b-d6795acc0956 | 2023-10-03 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Proficient Rx LP | f882d34f-6b9f-4d9d-8a3e-3054ba91c506 | 2023-07-01 | Boxed warning, Warnings, Adverse reactions | ANDA200295 903456 GCA9VV7D2N |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | SIGMAPHARM LABORATORIES, LLC | 38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c | 2023-01-10 | Boxed warning, Warnings, Adverse reactions | ANDA200295 42794-018 903456 903697 903703 f1f181e3-ceed-1d17-e053-2995a90af5cd 38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c GCA9VV7D2N |
| Liothyronine Sodium | LIOTHYRONINE SODIUM | Teva Pharmaceuticals USA, Inc. | 548d684a-86f5-4e57-9844-d8cf0a84e068 | 2020-07-01 | Boxed warning, Warnings, Adverse reactions | 903456 903697 903703 GCA9VV7D2N |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.